nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2005-9-1-9-19nefr-787Research ArticleПЕРЕДОВАЯ СТАТЬЯLEADING ARTICLEЛЕПТИН – НОВЫЙ ГОРМОН ЖИРОВОЙ ТКАНИ: ЗНАЧЕНИЕ В РАЗВИТИИ ОЖИРЕНИЯ, ПАТОЛОГИИ СЕРДЕЧНО-СОСУДИСТОЙ СИСТЕМЫ И ПОЧЕКLEPTIN - A NEW ADIPOSE TISSUE HORMONE: SIGNIFICANCE IN THE DEVELOPMENT OF OBESITY, DISEASES OF THE CARDIOVASCULAR SYSTEM AND KIDNEYSКучерА. Г.KucherA. G.

Кафедра пропедевтики внутренних болезней

СмирновА. В.SmirnovA. V.

Кафедра пропедевтики внутренних болезней

КаюковИ. Г.KayukovI. G.

Кафедра пропедевтики внутренних болезней

ДобронравовВ. А.DobronravovV. A.

Кафедра пропедевтики внутренних болезней

ЯковенкоА. А.YakovenkoA. A.

Кафедра пропедевтики внутренних болезней

Научно-исследовательский институт нефрологии, Санкт-Петербургский государственный медицинский университет им. акад. И.П. ПавловаRussian Federation20051001200591919Copyright © Кучер А.Г., Смирнов А.В., Каюков И.Г., Добронравов В.А., Яковенко А.А., 20052005Кучер А.Г., Смирнов А.В., Каюков И.Г., Добронравов В.А., Яковенко А.А.Kucher A.G., Smirnov A.V., Kayukov I.G., Dobronravov V.A., Yakovenko A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/787

Лептин новый гормон жировой ткани: значение в развитии ожирения, патологии сердечнососудистой системы и почек.

Leptin a new adipose tissue hormone: significance in the development of obesity, diseases of the cardiovascular system and kidneys.

лептинфункцииожирениесердечнососудистая системапочкиleptinfunctionsobesitycardiovascular systemkidneysReferencesПанков ЮА. Все органы, ткани и клетки животных и человека являются эндокринными. Вестник РАМН 2001;5:14 19Панков ЮА. Все органы, ткани и клетки животных и человека являются эндокринными. Вестник РАМН 2001;5:14 19Kennedy G. The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc London 1953;140:578 592Kennedy G. The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc London 1953;140:578 592Hervey G. The effects of lesions in the hypothalamus in parabiotic rats. J Physiol 1959;145:338352Hervey G. The effects of lesions in the hypothalamus in parabiotic rats. J Physiol 1959;145:338352Coleman G, Hummel K. Effects of parabiosis of normal with genetically diabetic mice. Am J Physiol 1969;217:1298 1304Coleman G, Hummel K. Effects of parabiosis of normal with genetically diabetic mice. Am J Physiol 1969;217:1298 1304Coleman G. Effects of parabiosis with diabetes and normal mice. Diabetologia 1973;9: 294298Coleman G. Effects of parabiosis with diabetes and normal mice. Diabetologia 1973;9: 294298Zhang Y, Proenca R, Maffei M et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1995;372:425432Zhang Y, Proenca R, Maffei M et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1995;372:425432Kershaw ES, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89(6):25482556Kershaw ES, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89(6):25482556Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21:697738Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21:697738Fain JN, Madan AK, Hiler ML et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissue of obese humans. Endocrinology 2004;145:2273 2282Fain JN, Madan AK, Hiler ML et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissue of obese humans. Endocrinology 2004;145:2273 2282Wiecek A, Kokot F, Chudek J, Adamczak M. The adipose tissue – a novel endocrine organ of interest to the nephrologists. Nephrol Dial Transplant 2002;17(2):191195Wiecek A, Kokot F, Chudek J, Adamczak M. The adipose tissue – a novel endocrine organ of interest to the nephrologists. Nephrol Dial Transplant 2002;17(2):191195Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 2002;26:14071433Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 2002;26:14071433Tartaglia LA, Dembski M, Weng X et al. Identification and expression cloning of a leptin receptor, OBR. Cell 1995;83:12631271Tartaglia LA, Dembski M, Weng X et al. Identification and expression cloning of a leptin receptor, OBR. Cell 1995;83:12631271Chen H, Charlat O, Tartaglia LA et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996;84:491495Chen H, Charlat O, Tartaglia LA et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996;84:491495Lee GH, Proenca R, Montez JM et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996;379:632 635Lee GH, Proenca R, Montez JM et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996;379:632 635Bjorback C, Kahn BB. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 2004;59:305331Bjorback C, Kahn BB. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 2004;59:305331Le Cava A, Alviggi C, Matarese G. Unraveling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med 2004;82(1):411Le Cava A, Alviggi C, Matarese G. Unraveling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med 2004;82(1):411SerradeilLe Gal C, Raufaste D, Brossard G et al. Characterization and localization of leptin receptors in the rat kidney. FEBS Lett 1997;404:185191SerradeilLe Gal C, Raufaste D, Brossard G et al. Characterization and localization of leptin receptors in the rat kidney. FEBS Lett 1997;404:185191Wolf G, Hamann A, Han DC et al. Leptin stimulates proliferation and TGFІ expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int 1999;56(3):860872Wolf G, Hamann A, Han DC et al. Leptin stimulates proliferation and TGFІ expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int 1999;56(3):860872Панков ЮА. Лептин – новый гормон в эндокриноло гии. Успехи физиологических наук 2003;34(2):320Панков ЮА. Лептин – новый гормон в эндокриноло гии. Успехи физиологических наук 2003;34(2):320Zeibel RL. The role of leptin in the control of body weight. Nutrition Reviews 2002;60 (10, pt2):s15s19Zeibel RL. The role of leptin in the control of body weight. Nutrition Reviews 2002;60 (10, pt2):s15s19Rosenbaum M, Nicolson M, Hirsch J et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996;81:3424 3427Rosenbaum M, Nicolson M, Hirsch J et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996;81:3424 3427Horlick M, Rosenbaum M, Nicolson M et al. Effect of puberty on the relationship between circulating leptin and body composition. J Clin Endocrinol Metab 2000;85:25092518Horlick M, Rosenbaum M, Nicolson M et al. Effect of puberty on the relationship between circulating leptin and body composition. J Clin Endocrinol Metab 2000;85:25092518Harmelen VV, Reynisdottir S, Eriksson P et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998;47:913917Harmelen VV, Reynisdottir S, Eriksson P et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998;47:913917Ahima RS, Flier JS. Leptin. Annu Rev Physiol 2000;62:413437Ahima RS, Flier JS. Leptin. Annu Rev Physiol 2000;62:413437Rosenbaum M, Pietrobelli A, Vasselli J et al. Sexual dimorphism in circulating leptin concentrations is not accounted for by dimorphism in adipose tissue distribution. Int J Obes 2001;25:13651371Rosenbaum M, Pietrobelli A, Vasselli J et al. Sexual dimorphism in circulating leptin concentrations is not accounted for by dimorphism in adipose tissue distribution. Int J Obes 2001;25:13651371Bjorback C, Elmquist JK, Frantz JD et al. Identification of SOCS3 as a potential mediator of central leptin resistance. Mol Cell 1998;1:619625Bjorback C, Elmquist JK, Frantz JD et al. Identification of SOCS3 as a potential mediator of central leptin resistance. Mol Cell 1998;1:619625Flier JS. Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004;116:337350Flier JS. Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004;116:337350Havel PJ. Role of adipose tissue in body – weight regulation: mechanisms regulating leptin production and energy balance. Proc Nutr Soc 2000;59:359371Havel PJ. Role of adipose tissue in body – weight regulation: mechanisms regulating leptin production and energy balance. Proc Nutr Soc 2000;59:359371Hall JE, Crook ED, Jones DW et al. Mechanisms of obesity – associated cardiovascular and renal disease. Am J Med Sciences 2002;324:127137Hall JE, Crook ED, Jones DW et al. Mechanisms of obesity – associated cardiovascular and renal disease. Am J Med Sciences 2002;324:127137Jequier E. Leptin signaling. Cellular Signaling 2002;14:655663Jequier E. Leptin signaling. Cellular Signaling 2002;14:655663Hayness WG, Morgan DA, Walsh SA et al. Receptor mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997;100:270278Hayness WG, Morgan DA, Walsh SA et al. Receptor mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997;100:270278Unger RH, Orci L. Lipoapoptosis: its mechanism and its diseases. Biochem Biophys Acta 2002;1585:202212Unger RH, Orci L. Lipoapoptosis: its mechanism and its diseases. Biochem Biophys Acta 2002;1585:202212Wang J, Obici S, Morgan K et al. Overfeeding rapidly induces leptin and insulin resistance. Diabetes 2001;50:2786 2791Wang J, Obici S, Morgan K et al. Overfeeding rapidly induces leptin and insulin resistance. Diabetes 2001;50:2786 2791Trayhurn P, Duncan JS, Hoggard N, Rayner DV. Regulation of leptin production: a dominant role for the sympathetic nervous system. Proc Nutr Soc 1998;57:413419Trayhurn P, Duncan JS, Hoggard N, Rayner DV. Regulation of leptin production: a dominant role for the sympathetic nervous system. Proc Nutr Soc 1998;57:413419Evans BA, Agar L, Summers RJ. The role of the sympathetic nervous system in the regulation of leptin of leptin synthesis in C57BL/6 mice. FEBS Letters 1999;444:149154Evans BA, Agar L, Summers RJ. The role of the sympathetic nervous system in the regulation of leptin of leptin synthesis in C57BL/6 mice. FEBS Letters 1999;444:149154Eikelis N, Schlaich M, Aggarwal A et al. Interactions between leptin and the human sympathetic nervous system. Hypertension 2003;41:10721079Eikelis N, Schlaich M, Aggarwal A et al. Interactions between leptin and the human sympathetic nervous system. Hypertension 2003;41:10721079Matsumura K, Abe I, Tsuchihashi T, Fujishima M. Central effects of leptin on cardiovascular and neurohormonal responses in conscious rabbits. Am J Physiol Regulatory Integrative Comparative Physiol 2000;278:R1314R1320Matsumura K, Abe I, Tsuchihashi T, Fujishima M. Central effects of leptin on cardiovascular and neurohormonal responses in conscious rabbits. Am J Physiol Regulatory Integrative Comparative Physiol 2000;278:R1314R1320Shirasaka T, Takasaki M, Kannan H. Cardivascular effects of leptin and orexins. Am J Physiol Regulatory Integrative Comparative Physiology 2003;284:R639R651Shirasaka T, Takasaki M, Kannan H. Cardivascular effects of leptin and orexins. Am J Physiol Regulatory Integrative Comparative Physiology 2003;284:R639R651Satoh N, Ogawa Y, Katsuura G. et al. Sympathetic activation of leptin via the ventromedial hypothalamus: leptin induced increase in catecholamine secretion. Diabetes 1999;48:17871793Satoh N, Ogawa Y, Katsuura G. et al. Sympathetic activation of leptin via the ventromedial hypothalamus: leptin induced increase in catecholamine secretion. Diabetes 1999;48:17871793Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension 1998;31:409414Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension 1998;31:409414Kimura K, Tsuda K, Baba A. et al. Involvement of nitric oxide in endotheliumdependent arterial relaxation by leptin. Biochem Biophysic Res Commun 2000;273:745749Kimura K, Tsuda K, Baba A. et al. Involvement of nitric oxide in endotheliumdependent arterial relaxation by leptin. Biochem Biophysic Res Commun 2000;273:745749Quehenberger P, Exner M, SunderPlassmann R et al. Leptin induces endothelin1 in endothelial cells in vitro. Circul Res 2002;90:711718Quehenberger P, Exner M, SunderPlassmann R et al. Leptin induces endothelin1 in endothelial cells in vitro. Circul Res 2002;90:711718Vecchione C, Maffei A, Colella S et al. Leptin effect on endothelial nitric oxide is mediated through Aktendothelial nitric oxide synthase phosphorylation pathway. Diabetes 2002;51:168173Vecchione C, Maffei A, Colella S et al. Leptin effect on endothelial nitric oxide is mediated through Aktendothelial nitric oxide synthase phosphorylation pathway. Diabetes 2002;51:168173Nakagawa K, Higashi Y, Sasaki S. et al. Leptin causes vasodilatation in humans. Hypertension Research 2002;25:161 165Nakagawa K, Higashi Y, Sasaki S. et al. Leptin causes vasodilatation in humans. Hypertension Research 2002;25:161 165Fruhbeck G. Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 1999;48:903908Fruhbeck G. Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 1999;48:903908Narkiewicz K, Somers VK, Mos L et al. An independent relationship between plasma leptin and heart rate in untreated patients with essential hypertension. J Hypertension 1999;17:245249Narkiewicz K, Somers VK, Mos L et al. An independent relationship between plasma leptin and heart rate in untreated patients with essential hypertension. J Hypertension 1999;17:245249Sowers JR. Obesity and cardiovascular disease. Clin Chem 1998;44:18211825Sowers JR. Obesity and cardiovascular disease. Clin Chem 1998;44:18211825Ren J. Leptin and hyperleptinemia from friend to foe for cardiovascular function. J Endocrinol 2004;181(1):110Ren J. Leptin and hyperleptinemia from friend to foe for cardiovascular function. J Endocrinol 2004;181(1):110Winnicki M, Phillips BG, Accurso V et al. Independent association between plasma leptin levels and heart rate in heart transplant recipients. Circulation 2001;104:384386Winnicki M, Phillips BG, Accurso V et al. Independent association between plasma leptin levels and heart rate in heart transplant recipients. Circulation 2001;104:384386Singhal A, Faroogi IS, Cole TJ et al. Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? Circulation 2002;106:19191924Singhal A, Faroogi IS, Cole TJ et al. Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? Circulation 2002;106:19191924Parhami F, Tintut Y, Ballard A et al. Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res 2001;88:954960Parhami F, Tintut Y, Ballard A et al. Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res 2001;88:954960Konstantinides S, Schafer K, Kaschnick S, Zoskutoff DJ. Leptindependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest 2001;8:15331540Konstantinides S, Schafer K, Kaschnick S, Zoskutoff DJ. Leptindependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest 2001;8:15331540Winnicki M, Somers VK, Accurs V et al. Fishrich diet, leptin and body mass. Circulation 2002;106(3):289291Winnicki M, Somers VK, Accurs V et al. Fishrich diet, leptin and body mass. Circulation 2002;106(3):289291Bjorback C, ElHaschimi K, Frantz JD, Flier JS. The role of SOCS3 in leptin signaling and leptin resistance. J Biol Chem 1999;274:3005930065Bjorback C, ElHaschimi K, Frantz JD, Flier JS. The role of SOCS3 in leptin signaling and leptin resistance. J Biol Chem 1999;274:3005930065Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997;46:310Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997;46:310Wang J, Liu R, Liu L et al. The effect of leptin on Lep expression is tissuespecific and nutritionally regulated. Nature Med 1999;5:895899Wang J, Liu R, Liu L et al. The effect of leptin on Lep expression is tissuespecific and nutritionally regulated. Nature Med 1999;5:895899Mark AL., Correria ML, Rahmouni K, Haynes WG. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hyper 2002;20:12451250Mark AL., Correria ML, Rahmouni K, Haynes WG. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hyper 2002;20:12451250Kobot F, Chudek J, Adamczak M, Wiecek A. Interrelationship between plasma leptin concentration and severity of metabolic acidosis in hemodialysed patients with chronical renal failure. Exp Clin Endocrinol Diabetes 2001;109(7):370373Kobot F, Chudek J, Adamczak M, Wiecek A. Interrelationship between plasma leptin concentration and severity of metabolic acidosis in hemodialysed patients with chronical renal failure. Exp Clin Endocrinol Diabetes 2001;109(7):370373Stenvinkel P, Heimburger O. The Enigma of increasing serum leptin levels during peritoneal dialysis. Am J Kidn Dis 1999;34(5):947950Stenvinkel P, Heimburger O. The Enigma of increasing serum leptin levels during peritoneal dialysis. Am J Kidn Dis 1999;34(5):947950Merabet E, DagogoJack S, Coyne DW et al. Increased plasma leptin concentration in endstage renal disease. J Clin Endocrinol Metab 1997;82:847850Merabet E, DagogoJack S, Coyne DW et al. Increased plasma leptin concentration in endstage renal disease. J Clin Endocrinol Metab 1997;82:847850Cumin F, Baum HP, Levens N. Mechanism of leptin removal from the circulation by the kidney. J Endocrinol 1997;155:577585Cumin F, Baum HP, Levens N. Mechanism of leptin removal from the circulation by the kidney. J Endocrinol 1997;155:577585Meyer C, Roson D, Rackovsky N et al. Role of the kidney in human leptin metabolism. Am J Physiol 1997;273:E903E907Meyer C, Roson D, Rackovsky N et al. Role of the kidney in human leptin metabolism. Am J Physiol 1997;273:E903E907Wolf G, Hamann A, Han DC et al. Leptin stimulates proliferation and TGFІ expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int 1999;56(3):860872Wolf G, Hamann A, Han DC et al. Leptin stimulates proliferation and TGFІ expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int 1999;56(3):860872Kambham N, Markowitz GS, Valeri AM et al. Obesity related glomerulopathy: an emerging epidemic. Kidney Int 2001;59:14981509Kambham N, Markowitz GS, Valeri AM et al. Obesity related glomerulopathy: an emerging epidemic. Kidney Int 2001;59:14981509Praga M, Hernandez E, Morales E et al. Clinical features and longterm outcome of obesityassociated focal segmental glomerulosclerosis. Nephrol Dial Transplant 2001;16:17901798Praga M, Hernandez E, Morales E et al. Clinical features and longterm outcome of obesityassociated focal segmental glomerulosclerosis. Nephrol Dial Transplant 2001;16:17901798Bonnet F, Deprele C, Sassolas A et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am Kidney Dis 2001;37:720727Bonnet F, Deprele C, Sassolas A et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am Kidney Dis 2001;37:720727MeierKrische HU, Arndorfer JA, Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 2002;73:7074MeierKrische HU, Arndorfer JA, Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 2002;73:7074Morales E, Valero A, Leon M et al. Benefical effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 2003;41:319327Morales E, Valero A, Leon M et al. Benefical effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 2003;41:319327Wolf G. After all those fat years: renal consequences of obesity. Nephrol Dial Transplant 2003;18(12):24712474Wolf G. After all those fat years: renal consequences of obesity. Nephrol Dial Transplant 2003;18(12):24712474Han DC, Isono M, Chen S et al. Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGFІ type II receptor expression. Kidn Int 2001;59(4):1315 1323Han DC, Isono M, Chen S et al. Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGFІ type II receptor expression. Kidn Int 2001;59(4):1315 1323Zhao AZ, Bornfeldt KE, Beavo JA. Leptin inhibits insulin secretion by activation of phosphodiesterase 3B. J Clin Invest 1998;102:869873Zhao AZ, Bornfeldt KE, Beavo JA. Leptin inhibits insulin secretion by activation of phosphodiesterase 3B. J Clin Invest 1998;102:869873Isono M, Mogyorosi A, Han DC et al. Stimulation of TGFІ type II receptor by high glucose in mouse mesangial cell and in diabetic kidney. Am J Physiol 2000;278:F830F838Isono M, Mogyorosi A, Han DC et al. Stimulation of TGFІ type II receptor by high glucose in mouse mesangial cell and in diabetic kidney. Am J Physiol 2000;278:F830F838Kasiske BL, Crosson T. Renal disease in patients with massive obesity. Arch Intern Med 1986;146:11051109Kasiske BL, Crosson T. Renal disease in patients with massive obesity. Arch Intern Med 1986;146:11051109Bossola M, Muscaritoli M, Valenza V et al. Anorexia and serum leptin levels in hemodialysis patients. Nephrol Clinical Practice 2004;97(3):7682Bossola M, Muscaritoli M, Valenza V et al. Anorexia and serum leptin levels in hemodialysis patients. Nephrol Clinical Practice 2004;97(3):7682Kokot F, Adamczak M, Wiecek A. Plasma leptin concentration in kidney transplant patients during the early posttransplant period. Nephrol Dial Transplant 1998;13:2276 2280Kokot F, Adamczak M, Wiecek A. Plasma leptin concentration in kidney transplant patients during the early posttransplant period. Nephrol Dial Transplant 1998;13:2276 2280Shoji T, Nishizawa Y, Emoto M et al. Renal function and insulin resistance as determinants of plasma leptin levels in patients with NIDDM. Diabetologia 1997;40:678679Shoji T, Nishizawa Y, Emoto M et al. Renal function and insulin resistance as determinants of plasma leptin levels in patients with NIDDM. Diabetologia 1997;40:678679Howard JK, Lord GM, Clutterback EJ et al. Plasma immunoreactive leptin concentration in endstage renal disease. Clin Sci Colch 1997;93:119126Howard JK, Lord GM, Clutterback EJ et al. Plasma immunoreactive leptin concentration in endstage renal disease. Clin Sci Colch 1997;93:119126Young GA, Woodrow G, Kendall S et al. Increased plasma leptin fat ratio in patients with chronic renal failure: it cause of malnutrition? Nephrol Dial Transplant 1997;12:23182323Young GA, Woodrow G, Kendall S et al. Increased plasma leptin fat ratio in patients with chronic renal failure: it cause of malnutrition? Nephrol Dial Transplant 1997;12:23182323Iida N., Murakami T., Yamada M. et al. Hyperleptinemia in chronic renal failure. Horm Metab Res 1996;28:724727Iida N., Murakami T., Yamada M. et al. Hyperleptinemia in chronic renal failure. Horm Metab Res 1996;28:724727Heimburger O, Lonngvist F, Danielsson et al. Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 1997;8:14231430Heimburger O, Lonngvist F, Danielsson et al. Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 1997;8:14231430Nakazono H, Nagake Y, Ichikawa H et al. Serum leptin concentrations in patients on hemodialysis. Nephron 1998;80:3540Nakazono H, Nagake Y, Ichikawa H et al. Serum leptin concentrations in patients on hemodialysis. Nephron 1998;80:3540Nishizawa Y, Shoji T, Tanaka S et al. Plasma leptin level and its relationship with body composition in hemodialysis patients. Am J Kidney Dis 1998;31:655661Nishizawa Y, Shoji T, Tanaka S et al. Plasma leptin level and its relationship with body composition in hemodialysis patients. Am J Kidney Dis 1998;31:655661Cumin F, Baum HP, Levens N. Leptin is cleared from the circulation primary by the kidney. Int J Obes Relat Metab Disord 1996;20:11201126Cumin F, Baum HP, Levens N. Leptin is cleared from the circulation primary by the kidney. Int J Obes Relat Metab Disord 1996;20:11201126Perez Fontan M, RodriguezCarmona A, Cordido F et al. Hyperleptinemia in uremic patients undergoing conservative management, peritoneal dialysis and hemodialysis: A comparative analysis. Am J Kidney Dis 1999;34(5):824831Perez Fontan M, RodriguezCarmona A, Cordido F et al. Hyperleptinemia in uremic patients undergoing conservative management, peritoneal dialysis and hemodialysis: A comparative analysis. Am J Kidney Dis 1999;34(5):824831Kagan A, Haran N, Leschinsky L et al. Leptin in CAPD patients: Serum concentrations and peritoneal loss. Nephrol Dial Transplant 1999;14:400405Kagan A, Haran N, Leschinsky L et al. Leptin in CAPD patients: Serum concentrations and peritoneal loss. Nephrol Dial Transplant 1999;14:400405DagogoJack S. Uremic hyperleptinemia: Adaptive or maladaptive. Kidn Int 1998;54:997998DagogoJack S. Uremic hyperleptinemia: Adaptive or maladaptive. Kidn Int 1998;54:997998Wiesholzer M, Harm F, Hauser AC et al. Inappropriately plasma leptin levels in obese hemodialysis patients can be reduced by high flux haemodialysis and haemofiltration. Clin Sci Colch 1998;94:431435Wiesholzer M, Harm F, Hauser AC et al. Inappropriately plasma leptin levels in obese hemodialysis patients can be reduced by high flux haemodialysis and haemofiltration. Clin Sci Colch 1998;94:431435Wideroe TE, Smeby L, Myking O. Plasma concentrations and transperitoneal transport of native insulin and Cpeptide in patients on continuous ambulatory peritoneal dialysis. Kidney Int 1984;25:.8287Wideroe TE, Smeby L, Myking O. Plasma concentrations and transperitoneal transport of native insulin and Cpeptide in patients on continuous ambulatory peritoneal dialysis. Kidney Int 1984;25:.8287Wang J, Liu R, Hawkins M et al. A nutrientsensing pathway regulates leptin expression in muscle and fat. Nature 1998;393:684688Wang J, Liu R, Hawkins M et al. A nutrientsensing pathway regulates leptin expression in muscle and fat. Nature 1998;393:684688Tsujimoto Y, Shoji T, Tabata T et al. Leptin in peritoneal dialysate from CAPD patients. Am J Kidney Dis 1999;34:823 838Tsujimoto Y, Shoji T, Tabata T et al. Leptin in peritoneal dialysate from CAPD patients. Am J Kidney Dis 1999;34:823 838Fongue D, Juillard L, Lasne Y et al. Acute leptin regulation in endstage failure: The role of growth hormone and IFG1. Kidney Int 1998;54:932937Fongue D, Juillard L, Lasne Y et al. Acute leptin regulation in endstage failure: The role of growth hormone and IFG1. Kidney Int 1998;54:932937Garibotti G, Russo R, Franceschini R et al. Interorgan leptin exchange in humans. Biochem Biophys Res Commun 1998;247:504509Garibotti G, Russo R, Franceschini R et al. Interorgan leptin exchange in humans. Biochem Biophys Res Commun 1998;247:504509Mamoun AH. Anorexia in patients with chronic renal failure: Progress towards understanding the molecular basis. Nephrol Dial Transplant 1998;13:24602463Mamoun AH. Anorexia in patients with chronic renal failure: Progress towards understanding the molecular basis. Nephrol Dial Transplant 1998;13:24602463PlataSalaman CR. Leptin and anorexia in renal insufficiency. Nephron Clinical Practice 2004;97(3):7375PlataSalaman CR. Leptin and anorexia in renal insufficiency. Nephron Clinical Practice 2004;97(3):7375Yohansen KL, Mulligan K, Tai V et al. Leptin, body composition, and indices of malnutrition in patients on dialysis. J Am Soc Nephrol 1998;9:10801084Yohansen KL, Mulligan K, Tai V et al. Leptin, body composition, and indices of malnutrition in patients on dialysis. J Am Soc Nephrol 1998;9:10801084Don BR, Rosales LM, Levine NW et al. Leptin is a negative acute phase protein in chronic hemodialysis patients. Kidney Int 2001;59:11141120Don BR, Rosales LM, Levine NW et al. Leptin is a negative acute phase protein in chronic hemodialysis patients. Kidney Int 2001;59:11141120Stenvinkel P, Lindholm B, Lonngvist F et al. Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol 2000;1:13031309Stenvinkel P, Lindholm B, Lonngvist F et al. Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol 2000;1:13031309Odamaki M, Furuga R, Yoneyata T et al. Association of the serum leptin concentration with weight loss in chronic hemodialysis patients. Am J Kidney Dis 1999;33:361368Odamaki M, Furuga R, Yoneyata T et al. Association of the serum leptin concentration with weight loss in chronic hemodialysis patients. Am J Kidney Dis 1999;33:361368Savage DB, O’Rahilly S. Leptin: a novel therapeutic role in lipodystrophy. J Clin Invest 2002;109(10):12851286Savage DB, O’Rahilly S. Leptin: a novel therapeutic role in lipodystrophy. J Clin Invest 2002;109(10):12851286Mantzoros CS, Flijer JS. Editorial: Leptin as a therapeutic agenttrials and tribulations. J Clin Endocrinol Metabol 2000;85(11):40004002Mantzoros CS, Flijer JS. Editorial: Leptin as a therapeutic agenttrials and tribulations. J Clin Endocrinol Metabol 2000;85(11):40004002Ahima R, Osei SY. Editorial: Leptin and appetite control in lipodistrophy. J Clin Endocrinol Metab 2004;89(9):42544257Ahima R, Osei SY. Editorial: Leptin and appetite control in lipodistrophy. J Clin Endocrinol Metab 2004;89(9):42544257Fujioka K, Patane J, Lubina J, Lau D. CSF leptin levels after exogenous administration of recombinant methionyl human leptin. J Am Med Assoc 1999;282:15171518Fujioka K, Patane J, Lubina J, Lau D. CSF leptin levels after exogenous administration of recombinant methionyl human leptin. J Am Med Assoc 1999;282:15171518Faroogi IS, Jebb SA, Langmack G et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999;341:879884Faroogi IS, Jebb SA, Langmack G et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999;341:879884Heymsfield SB, Greenberg AS, Fujioka K et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, doseescalation trial. JAMA 1999;282:15681575Heymsfield SB, Greenberg AS, Fujioka K et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, doseescalation trial. JAMA 1999;282:15681575Hukshorn CJ, Saris WHM, WesterterPlantenga MC et al. Weekly subcutaneous pegylated recombinant native human leptin (PEGOB) administration in obese men. J Clin Endocrinol Metab 2000;46:249256Hukshorn CJ, Saris WHM, WesterterPlantenga MC et al. Weekly subcutaneous pegylated recombinant native human leptin (PEGOB) administration in obese men. J Clin Endocrinol Metab 2000;46:249256Konstantinides S, Schafer K, Loskutoff DJ. The prothrombotic effects leptin possible implications for the risk, of cardiovascular disease in obesity. Ann N Y Acad Sci 2001;947:134141Konstantinides S, Schafer K, Loskutoff DJ. The prothrombotic effects leptin possible implications for the risk, of cardiovascular disease in obesity. Ann N Y Acad Sci 2001;947:134141Quehenberger P, Exner M, SunderPlassmann R et al. Leptin induces endothelin1 in endothelial cells in vitro. Circ Res 2002;90:711718Quehenberger P, Exner M, SunderPlassmann R et al. Leptin induces endothelin1 in endothelial cells in vitro. Circ Res 2002;90:711718Garg A. Lipodystrophies. Am J Med 2000;108:143 152Garg A. Lipodystrophies. Am J Med 2000;108:143 152Oral EA, Simha V, Ruiz E et al. Leptinreplacement therapy for lipodystrophy. N Engl J Med 2002;346:570578Oral EA, Simha V, Ruiz E et al. Leptinreplacement therapy for lipodystrophy. N Engl J Med 2002;346:570578Petersen KF, Oral EA, Dufour S et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Cli Invest 2002;109:134 51350Petersen KF, Oral EA, Dufour S et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Cli Invest 2002;109:134 51350

The authors declare that there are no conflicts of interest present.